Co-Diagnostics, Inc. Equity Method Investment, Realized Gain (Loss) on Disposal
Co-Diagnostics, Inc. (CODX) reported Equity Method Investment, Realized Gain (Loss) on Disposal of -$430.43 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-24.
Discontinued › Income Statement › Other Income
us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal · last filed 2022-03-24
- Co-Diagnostics, Inc. equity method investment, realized gain (loss) on disposal for the quarter ending 2021-12-31 was -$29.14K.
- Co-Diagnostics, Inc. equity method investment, realized gain (loss) on disposal for the quarter ending 2021-09-30 was -$64.94K, a 108.68% decline year-over-year.
- Co-Diagnostics, Inc. equity method investment, realized gain (loss) on disposal for the quarter ending 2021-06-30 was $128.59K, a 50.26% decline year-over-year.
- Co-Diagnostics, Inc. equity method investment, realized gain (loss) on disposal for the quarter ending 2021-03-31 was -$464.94K, a 5164.19% decline year-over-year.
- Co-Diagnostics, Inc. equity method investment, realized gain (loss) on disposal for fiscal 2021 was -$430.43K, a 155.30% decline from fiscal 2020.
- Co-Diagnostics, Inc. equity method investment, realized gain (loss) on disposal for fiscal 2020 was $778.38K.
- Co-Diagnostics, Inc. equity method investment, realized gain (loss) on disposal for fiscal 2019 was -$232.88K.
| Period end | Equity Method Investment, Realized Gain (Loss) on Disposal 3 month | Equity Method Investment, Realized Gain (Loss) on Disposal 6 month | Equity Method Investment, Realized Gain (Loss) on Disposal 9 month | Equity Method Investment, Realized Gain (Loss) on Disposal 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$29.14K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$94.08K derived: sum of 2 quarters · filed 2022-03-24 | $34.51K derived: sum of 3 quarters · filed 2022-03-24 | -$430.43K 10-K · filed 2022-03-24 |
| 2021-09-30 | -$64.94K 10-Q · filed 2021-11-12 | $63.66K derived: sum of 2 quarters · filed 2021-11-12 | -$401.29K 10-Q · filed 2021-11-12 | -$639.20K derived: sum of 4 quarters · filed 2022-03-24 |
| 2021-06-30 | $128.59K 10-Q · filed 2021-08-12 | -$336.35K 10-Q · filed 2021-08-12 | -$574.26K derived: sum of 3 quarters · filed 2022-03-24 | $174.30K derived: sum of 4 quarters · filed 2022-03-24 |
| 2021-03-31 | -$464.94K 10-Q · filed 2021-05-13 | -$702.86K derived: sum of 2 quarters · filed 2022-03-24 | $45.70K derived: sum of 3 quarters · filed 2022-03-24 | $304.26K derived: sum of 4 quarters · filed 2022-03-24 |
| 2020-12-31 | -$237.91K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $510.64K derived: sum of 2 quarters · filed 2022-03-24 | $769.20K derived: sum of 3 quarters · filed 2022-03-24 | $778.38K 10-K · filed 2022-03-24 |
| 2020-09-30 | $748.56K 10-Q · filed 2021-11-12 | $1.01M derived: sum of 2 quarters · filed 2021-11-12 | $1.02M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $258.56K 10-Q · filed 2021-08-12 | $267.74K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $9.18K 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | -$232.88K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |